TRV GP IV, LLC
Related Filers (14)
- Third Rock Ventures GP IV, L.P. (15)
- Third Rock Ventures IV, L.P. (15)
- LEVIN MARK J (6)
- STARR KEVIN P (6)
- Third Rock Ventures GP III, L.P. (6)
- TEPPER ROBERT I (6)
- Third Rock Ventures III, L.P. (6)
- TRV GP III, LLC (6)
- Magenta Therapeutics, Inc. (4)
- Relay Therapeutics, Inc. (4)
- Fulcrum Therapeutics, Inc. (2)
- Revolution Medicines, Inc. (2)
- PLIANT THERAPEUTICS, INC. (2)
- Tango Therapeutics, Inc. (1)
- Show More ...
Other (21)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/10/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/12/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/3/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/12/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/10/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/5/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/11/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/12/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/6/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/7/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/11/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/5/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/4/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/6/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/3/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 1/28/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (15)
4
Thursday, 2/9/2023
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/26/2021
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/12/2021
Tango Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4/A
Thursday, 1/14/2021
Relay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/14/2021
Relay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/21/2020
Relay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/15/2020
Relay Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/9/2020
PLIANT THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/2/2020
PLIANT THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/18/2020
Revolution Medicines, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/12/2020
Revolution Medicines, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/22/2019
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Fulcrum Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/27/2018
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Magenta Therapeutics, Inc.: Initial statement of beneficial ownership of securities